Roby Reuven Zomer Insider Profile

4 Followers
Roby Reuven Zomer, Chief Executive Officer, Ten Percent Owner at Argent Biopharma, holds 5.29M shares in Argent Biopharma (Ticker: RGTLF), holds 17.44M shares in Graft Polymer (UK) PLC (Ticker: GB:GPL).
tipranks
Roby Reuven Zomer

Roby Reuven Zomer
Argent Biopharma (RGTLF)
Chief Executive Officer, Ten Percent Owner

Ranked #92,703 out of 99,218 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-72.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
98.56%
1.44%
A breakdown of Roby Reuven Zomer's holdings

Insider Roles

Argent Biopharma
(RGTLF)
Chief Executive Officer, Ten Percent Owner
Graft Polymer (UK) PLC
(GPL)
Director, Ten Percent Owner
Roles that Roby Reuven Zomer holds in companies

Most Profitable Insider Trade

Stock:
Argent Biopharma
(RGTLF)
Rating:Informative Buy
Date:Sep 12, 2024 - Today
Return:-66.50%
The most profitable trade made by Roby Reuven Zomer

Roby Reuven Zomer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Argent Biopharma
Oct 15, 2024
Chief Executive Officer, Ten Percent Owner
Uninformative Buy
$1.91M
Graft Polymer (UK) PLC
Jan 08, 2024
Director, Ten Percent Owner
Informative Buy
66.67K
£27.90K
List of latest transactions for each holding click on a transaction to see Roby Reuven Zomer's performance on stock

Roby Reuven Zomer insider profile FAQ

What is the percentage of profitable transactions made by Roby Reuven Zomer?
The percentage of profitable transactions made by Roby Reuven Zomer is 0%.
    What is the average return per transaction made by Roby Reuven Zomer?
    The average return per transaction made by Roby Reuven Zomer is -72.10%.
      What stocks does Roby Reuven Zomer hold?
      Roby Reuven Zomer holds: RGTLF, GB:GPL stocks.
        What was Roby Reuven Zomer’s latest transaction?
        Roby Reuven Zomer latest transaction was an Uninformative Buy of ―.
          What was Roby Reuven Zomer's most profitable transaction?
          Roby Reuven Zomer’s most profitable transaction was an Informative Buy of RGTLF stock on September 12, 2024. The return on the trade was -66.50%.
            What is Roby Reuven Zomer's role in Argent Biopharma?
            Roby Reuven Zomer's role in Argent Biopharma is Chief Executive Officer, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.